The estimated Net Worth of Craig B Reynolds is at least $2.4 Milione dollars as of 26 June 2024. Mr. Reynolds owns over 1,228 units of Masimo Corp stock worth over $2,127,816 and over the last 17 years he sold MASI stock worth over $0. In addition, he makes $274,887 as Independent Director at Masimo Corp.
Sign up
Mr. Reynolds MASI stock SEC Form 4 insiders trading
Craig has made over 17 trades of the Masimo Corp stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 1,228 units of MASI stock worth $140,225 on 26 June 2024.
The largest trade he's ever made was exercising 78,964 units of Masimo Corp stock on 12 December 2007 worth over $1,540,588. On average, Craig trades about 10,259 units every 263 days since 2007. As of 26 June 2024 he still owns at least 18,634 units of Masimo Corp stock.
You can see the complete history of Mr. Reynolds stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Craig Reynolds biography
Craig B. Reynolds is an Independent Director of Masimo Corp. Mr. Reynolds is currently Chief Executive Officer and a director of Cereve, Inc., a medical company engaged in resolving insomnia issues. Prior to joining Cereve, Mr. Reynolds served as Chief Operating Officer of Philips-Respironics Home Health Solutions (“Philips-Respironics”), a subsidiary of Philips, from 2008 to 2010. Prior to Philips-Respironics, Mr. Reynolds was the Chief Operating Officer and a board member of Respironics, Inc., a company that develops, manufactures and markets medical devices worldwide, from 1998 to 2008. From 1993 to 1998, Mr. Reynolds was with Healthdyne Technologies, Inc., a medical device company, serving for five years as Chief Executive Officer and director. From 1981 through 1992, Mr. Reynolds was with Healthdyne, Inc. in the positions of Executive V.P. (1981 to 1983), President of Healthdyne Cardiovascular Division (1984 to 1985) and President of Healthdyne Homecare Division (1986 to 1992). From 2008 through 2014, Mr. Reynolds served as a director of Symmetry Medical, Inc., most recently as Chairman of the Board. He also served as Chairman of the Board of Symmetry Surgical, Inc. from 2014 through 2016. Mr. Reynolds earned his B.S. in Industrial Management from the Georgia Institute of Technology and his M.B.A. from Georgia State University.
What is the salary of Craig Reynolds?
As the Independent Director of Masimo Corp, the total compensation of Craig Reynolds at Masimo Corp is $274,887. There are 14 executives at Masimo Corp getting paid more, with Joseph Kiani having the highest compensation of $14,996,100.
How old is Craig Reynolds?
Craig Reynolds is 71, he's been the Independent Director of Masimo Corp since 2014. There are 4 older and 21 younger executives at Masimo Corp. The oldest executive at Masimo Corp is Thomas Harkin, 80, who is the Independent Director.
What's Craig Reynolds's mailing address?
Craig's mailing address filed with the SEC is C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE, CA, 92618.
Insiders trading at Masimo Corp
Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill e Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.
What does Masimo Corp do?
masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
What does Masimo Corp's logo look like?
Complete history of Mr. Reynolds stock trades at Masimo Corp, Vapotherm Inc e WisdomTree Trust
Masimo Corp executives and stock owners
Masimo Corp executives and other stock owners filed with the SEC include:
-
Joseph Kiani,
Chairman of the Board, Chief Executive Officer -
Bilal Muhsin,
Chief Operating Officer -
Joseph E. Kiani,
Founder, CEO & Chairman -
Tao Levy,
Executive Vice President - Business Development -
Anand Sampath,
Executive Vice President - Operations & Clinical Research -
Tom McClenahan,
Executive Vice President, General Counsel, Corporate Secretary -
Micah Young,
Chief Financial Officer, Executive Vice President -
Jon Coleman,
President - Worldwide Sales, Professional Services and Medical Affairs -
Yongsam Lee,
Executive Vice President, Chief Information Officer -
Bilal Muhsin,
Chief Operating Officer -
Micah Young,
Exec. VP of Fin. & CFO -
Thomas Samuel McClenahan,
Exec. VP, Gen. Counsel & Corp. Sec. -
Tao Leopold Levy,
Exec. VP of Bus. Devel. -
Adam Mikkelson,
Independent Director -
Craig Reynolds,
Independent Director -
Thomas Harkin,
Independent Director -
Sanford Fitch,
Independent Director -
H Michael Cohen,
Independent Director -
Julie Shimer,
Independent Director -
Steven Barker,
Director -
Dr. Steven J. Barker,
Chairman of Scientific Advisory Board & Chief Science Officer -
Eli Kammerman,
Investor Relations Officer -
J. Todd Koning,
Chief Accounting Officer -
Jon Coleman,
Pres of Worldwide Sales, Professional Services & Medical Affairs -
Yongsam Lee,
Exec. VP & Chief Information Officer -
Thierry Leclercq,
Exec. VP of Bus. Devel. -
Anand Sampath,
Exec. VP of Operations & Clinical Research -
Joe E Kiani,
CEO and Chairman of the Board -
Raad Mark De,
EVP & Chief Financial Officer -
Thierry Leclercq,
EVP, Bus Dev -
Paul Jansen,
Executive VP, Marketing -
Thomas Samuel Mc Clenahan,
EVP, GEN COUNSEL & CORP SEC -
Michelle Brennan,
Director -
Blair Tripodi,
COO, Consumer Division -
Christopher Kilpatrick,
EVP, Business Dev., GC & Sec. -
Olivier Berthon,
President, Masimo Europe -
Michael O'reilly,
EVP, Medical Affairs -
Ammar Al Ali,
Chief Technical Officer -
David Goodman,
EVP, Business Development -
Stephen M Moran,
EVP, General Counsel -
Stephen E. Paul,
Vice President, US Acute Care -
Rick Fishel,
President of Masimo Americas -
Robert Coleman,
Director -
Brian Campbell,
-
Mohamed Elmandjra,
Pres., Worldwide OEM Business -
Edward L Cahill,
Director -
Jack W Lasersohn,
Director -
Anthony Allan,
Chief Operating Officer -
Robert A Chapek,
Director -
Ramshorst David J Van,
SVP, Chief Accounting Officer -
Kevin P Duffy,
President, Consumer -
Capital Management Lp Polit...,
-
Rolf A Classon,
Director